The Urimon study: an initial study to investigate what changes occur in the profile of a series of substances during the development of a serious disease.
The diseases we are researching are cancer (all forms), cardiovascular diseases such as stroke or heart attack and diseases of the central nervous system such as Parkinson’s, MS (Multiple Sclerosis) and Alzheimer’s disease.
The importance of screening
The sooner a person knows whether he or she is ill, the sooner treatment can start. The earlier treatment can start, the higher the chance of cure. That, in a nutshell, is the essence of the Urimon study; nobody likes to hear that he or she is ill but if someone does get ill, he or she should know it soon. The Urimon study is the first step in the development of a system that monitors a person’s health in blood or urine.
The research questions of the study are:
- Is it possible to use the profile of this series of substances in blood or urine to get an early warning of the onset of serious diseases?
- Do the specific changes in the profile of the substances give an indication which disease is developing?
If we find changes in the profile of substances in samples taken before physical symptoms manifested, we will have answered the first research question positively. If we find different changes in people who develop cancer from those who develop cardiovascular disease, we have answered the second research question positively. Based on the answers to the two research questions, we will be able to make the decision to continue and expand the study or discontinue the study.
It is not yet possible to diagnose diseases with our measurements, so participants also do not risk that we “accidentally” find something. Instead, our research is designed to investigate whether that is possible in the future.
We adhere to the guidelines for good and ethical (medical) practice. For general information on your rights when processing your personal data, please consult the privacy statement and disclaimer at the bottom of this website. You can also consult the website of the Personal Data Authority.
This research was set up by You2Yourself BV based in Enschede and is conducted in cooperation with GPs, pharmacies and laboratories throughout the Netherlands. The medical ethics review committee of the University Medical Centre in Utrecht has approved this research. General information on research assessment can be found in the brochure ‘Medical-scientific research’. You can download this brochure here